Search

Francois P. Vandervegt

Examiner (ID: 18174)

Most Active Art Unit
1644
Art Unit(s)
1644, 1816, 1621
Total Applications
534
Issued Applications
281
Pending Applications
89
Abandoned Applications
164

Applications

Application numberTitle of the applicationFiling DateStatus
10/018314 Structure-based design of compounds that inhibit detrimental cytotoxic t lymphocyte responses May 21, 2002 Abandoned
Array ( [id] => 6110438 [patent_doc_number] => 20020172681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'Modulating Th2 cell levels via vMIP-I/CCR8 interaction' [patent_app_type] => new [patent_app_number] => 10/144883 [patent_app_country] => US [patent_app_date] => 2002-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9343 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20020172681.pdf [firstpage_image] =>[orig_patent_app_number] => 10144883 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/144883
Modulating Th2 cell levels via vMIP-I/CCR8 interaction May 13, 2002 Abandoned
Array ( [id] => 6829865 [patent_doc_number] => 20030180923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/139980 [patent_app_country] => US [patent_app_date] => 2002-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 551 [patent_figures_cnt] => 551 [patent_no_of_words] => 63506 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180923.pdf [firstpage_image] =>[orig_patent_app_number] => 10139980 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/139980
PRO4395 antibodies May 5, 2002 Issued
Array ( [id] => 7405637 [patent_doc_number] => 20040105862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Human TIMP-1 antibodies' [patent_app_type] => new [patent_app_number] => 10/128520 [patent_app_country] => US [patent_app_date] => 2002-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 18978 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20040105862.pdf [firstpage_image] =>[orig_patent_app_number] => 10128520 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/128520
Human TIMP-1 antibodies Apr 23, 2002 Issued
Array ( [id] => 408207 [patent_doc_number] => 07285525 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-23 [patent_title] => 'Suppression of immune response via inhibition of cathepsin S' [patent_app_type] => utility [patent_app_number] => 10/126223 [patent_app_country] => US [patent_app_date] => 2002-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12457 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/285/07285525.pdf [firstpage_image] =>[orig_patent_app_number] => 10126223 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/126223
Suppression of immune response via inhibition of cathepsin S Apr 18, 2002 Issued
Array ( [id] => 6821579 [patent_doc_number] => 20030219740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'DNA sequences isolated from human colonic epithelial cells' [patent_app_type] => new [patent_app_number] => 10/089887 [patent_app_country] => US [patent_app_date] => 2002-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44943 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20030219740.pdf [firstpage_image] =>[orig_patent_app_number] => 10089887 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/089887
DNA sequences isolated from human colonic epithelial cells Mar 28, 2002 Abandoned
Array ( [id] => 5786400 [patent_doc_number] => 20020160019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Identification of broadly reactive DR restricted epitopes' [patent_app_type] => new [patent_app_number] => 10/103395 [patent_app_country] => US [patent_app_date] => 2002-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 8896 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160019.pdf [firstpage_image] =>[orig_patent_app_number] => 10103395 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/103395
Identification of broadly reactive DR restricted epitopes Mar 19, 2002 Abandoned
Array ( [id] => 645647 [patent_doc_number] => 07119170 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-10 [patent_title] => 'Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases' [patent_app_type] => utility [patent_app_number] => 10/092404 [patent_app_country] => US [patent_app_date] => 2002-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6996 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/119/07119170.pdf [firstpage_image] =>[orig_patent_app_number] => 10092404 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/092404
Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases Mar 3, 2002 Issued
Array ( [id] => 6647395 [patent_doc_number] => 20030104472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Antibody specifically binding human pinch protein homolog' [patent_app_type] => new [patent_app_number] => 10/092066 [patent_app_country] => US [patent_app_date] => 2002-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16088 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20030104472.pdf [firstpage_image] =>[orig_patent_app_number] => 10092066 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/092066
Antibody specifically binding human pinch protein homolog Mar 3, 2002 Abandoned
Array ( [id] => 6476426 [patent_doc_number] => 20020151707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Immune mediators and related methods' [patent_app_type] => new [patent_app_number] => 10/081281 [patent_app_country] => US [patent_app_date] => 2002-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30035 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151707.pdf [firstpage_image] =>[orig_patent_app_number] => 10081281 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/081281
Immune mediators and related methods Feb 19, 2002 Abandoned
Array ( [id] => 5907904 [patent_doc_number] => 20020142944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'Treatment of ocular disorders' [patent_app_type] => new [patent_app_number] => 10/079931 [patent_app_country] => US [patent_app_date] => 2002-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3396 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20020142944.pdf [firstpage_image] =>[orig_patent_app_number] => 10079931 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/079931
Treatment of ocular disorders Feb 18, 2002 Abandoned
Array ( [id] => 7202801 [patent_doc_number] => 20040086960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Single chain class I major histo-compatibility complexes, constructs encoding same and methods of generating same' [patent_app_type] => new [patent_app_number] => 10/075257 [patent_app_country] => US [patent_app_date] => 2002-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14528 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20040086960.pdf [firstpage_image] =>[orig_patent_app_number] => 10075257 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/075257
Single chain class I major histo-compatibility complexes, constructs encoding same and methods of generating same Feb 14, 2002 Abandoned
Array ( [id] => 6258686 [patent_doc_number] => 20020187147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Antigen specific recombinant MHC class II molecules and methods of use' [patent_app_type] => new [patent_app_number] => 10/074257 [patent_app_country] => US [patent_app_date] => 2002-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 14455 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187147.pdf [firstpage_image] =>[orig_patent_app_number] => 10074257 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/074257
Antigen specific recombinant MHC class II molecules and methods of use Feb 13, 2002 Abandoned
Array ( [id] => 830284 [patent_doc_number] => 07399838 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-15 [patent_title] => 'Single chain class I major histo-compatibility complexes' [patent_app_type] => utility [patent_app_number] => 10/073300 [patent_app_country] => US [patent_app_date] => 2002-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 24 [patent_no_of_words] => 14883 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/399/07399838.pdf [firstpage_image] =>[orig_patent_app_number] => 10073300 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/073300
Single chain class I major histo-compatibility complexes Feb 12, 2002 Issued
Array ( [id] => 961211 [patent_doc_number] => 06951924 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-04 [patent_title] => 'Antibodies against secreted protein HTEBYII' [patent_app_type] => utility [patent_app_number] => 10/058993 [patent_app_country] => US [patent_app_date] => 2002-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 201196 [patent_no_of_claims] => 89 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/951/06951924.pdf [firstpage_image] =>[orig_patent_app_number] => 10058993 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/058993
Antibodies against secreted protein HTEBYII Jan 29, 2002 Issued
Array ( [id] => 5858579 [patent_doc_number] => 20020122820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-05 [patent_title] => 'Soluble MHC artificial antigen presenting cells' [patent_app_type] => new [patent_app_number] => 10/050231 [patent_app_country] => US [patent_app_date] => 2002-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6191 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20020122820.pdf [firstpage_image] =>[orig_patent_app_number] => 10050231 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/050231
Soluble MHC artificial antigen presenting cells Jan 15, 2002 Abandoned
Array ( [id] => 6177713 [patent_doc_number] => 20020156011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Compositions and methods for the therapy and diagnosis of colon cancer' [patent_app_type] => new [patent_app_number] => 10/046935 [patent_app_country] => US [patent_app_date] => 2002-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38366 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20020156011.pdf [firstpage_image] =>[orig_patent_app_number] => 10046935 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/046935
Compositions and methods for the therapy and diagnosis of colon cancer Jan 14, 2002 Abandoned
Array ( [id] => 6305360 [patent_doc_number] => 20020094332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-18 [patent_title] => 'Method of prophylaxis against large myocardial infractions' [patent_app_type] => new [patent_app_number] => 10/047608 [patent_app_country] => US [patent_app_date] => 2002-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3830 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20020094332.pdf [firstpage_image] =>[orig_patent_app_number] => 10047608 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/047608
Method of prophylaxis against large myocardial infractions Jan 13, 2002 Abandoned
Array ( [id] => 5921759 [patent_doc_number] => 20020115157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Intrinsically fluorescent, self-multimerizing MHC fusion proteins and complexes thereof' [patent_app_type] => new [patent_app_number] => 10/045949 [patent_app_country] => US [patent_app_date] => 2002-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 18452 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115157.pdf [firstpage_image] =>[orig_patent_app_number] => 10045949 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/045949
Intrinsically fluorescent, self-multimerizing MHC fusion proteins and complexes thereof Jan 10, 2002 Issued
09/913756 Tyrosine kinase receptor epha3 antigenic peptides Jan 4, 2002 Abandoned
Menu